NVCR logo

NovoCure Limited (NVCR) Working Capital

Annual Working Capital

$855.29 M
-$97.46 M-10.23%

31 December 2023

NVCR Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$360.27 M
-$563.39 M-61.00%

30 September 2024

NVCR Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVCR Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-10.2%-59.6%
3 y3 years-3.5%-61.9%
5 y5 years+233.1%+10.3%

NVCR Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-10.2%at low-62.5%at low
5 y5 years-10.2%+233.1%-62.5%+25.0%
alltimeall time-10.2%+808.3%-62.5%+282.6%

NovoCure Limited Working Capital History

DateAnnualQuarterly
Sept 2024
-
$360.27 M(-61.0%)
June 2024
-
$923.66 M(+9.6%)
Mar 2024
-
$842.48 M(-1.5%)
Dec 2023
$855.29 M(-10.2%)
$855.29 M(-4.0%)
Sept 2023
-
$890.84 M(-2.7%)
June 2023
-
$915.40 M(-2.6%)
Mar 2023
-
$940.22 M(-1.3%)
Dec 2022
$952.75 M(+2.3%)
$952.75 M(-0.9%)
Sept 2022
-
$961.30 M(+0.2%)
June 2022
-
$959.16 M(+0.7%)
Mar 2022
-
$952.78 M(+2.3%)
Dec 2021
$930.92 M(+5.1%)
$930.92 M(-1.4%)
Sept 2021
-
$944.46 M(+1.6%)
June 2021
-
$929.36 M(+2.7%)
Mar 2021
-
$904.75 M(+2.1%)
Dec 2020
$885.83 M(+150.5%)
$885.83 M(+207.4%)
Sept 2020
-
$288.15 M(-28.4%)
June 2020
-
$402.66 M(+6.5%)
Mar 2020
-
$377.98 M(+6.9%)
Dec 2019
$353.64 M
$353.64 M(+8.3%)
DateAnnualQuarterly
Sept 2019
-
$326.54 M(+10.2%)
June 2019
-
$296.42 M(+12.0%)
Mar 2019
-
$264.73 M(+3.1%)
Dec 2018
$256.81 M(+31.7%)
$256.81 M(+3.2%)
Sept 2018
-
$248.74 M(+1.7%)
June 2018
-
$244.64 M(+2.8%)
Mar 2018
-
$238.08 M(+22.1%)
Dec 2017
$194.93 M(-13.4%)
$194.93 M(-3.0%)
Sept 2017
-
$200.90 M(-0.2%)
June 2017
-
$201.32 M(-4.8%)
Mar 2017
-
$211.54 M(-6.0%)
Dec 2016
$224.99 M(-15.2%)
$224.99 M(-6.9%)
Sept 2016
-
$241.72 M(+20.8%)
June 2016
-
$200.08 M(-14.6%)
Mar 2016
-
$234.21 M(-11.7%)
Dec 2015
$265.28 M(+181.7%)
$265.28 M(+99.6%)
Sept 2015
-
$132.89 M(-16.3%)
June 2015
-
$158.68 M(+68.5%)
Dec 2014
$94.16 M(-43.9%)
$94.16 M
Dec 2013
$167.88 M
-

FAQ

  • What is NovoCure Limited annual working capital?
  • What is the all time high annual working capital for NovoCure Limited?
  • What is NovoCure Limited annual working capital year-on-year change?
  • What is NovoCure Limited quarterly working capital?
  • What is the all time high quarterly working capital for NovoCure Limited?
  • What is NovoCure Limited quarterly working capital year-on-year change?

What is NovoCure Limited annual working capital?

The current annual working capital of NVCR is $855.29 M

What is the all time high annual working capital for NovoCure Limited?

NovoCure Limited all-time high annual working capital is $952.75 M

What is NovoCure Limited annual working capital year-on-year change?

Over the past year, NVCR annual working capital has changed by -$97.46 M (-10.23%)

What is NovoCure Limited quarterly working capital?

The current quarterly working capital of NVCR is $360.27 M

What is the all time high quarterly working capital for NovoCure Limited?

NovoCure Limited all-time high quarterly working capital is $961.30 M

What is NovoCure Limited quarterly working capital year-on-year change?

Over the past year, NVCR quarterly working capital has changed by -$530.58 M (-59.56%)